nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant activity of QS-21 for experimental E. coli 018 polysaccharide vaccines
|
Coughlin, Richard T. |
|
1995 |
13 |
1 |
p. 17-21 5 p. |
artikel |
2 |
Adventitious pestivirus RNA in live virus vaccines against bovine and swine diseases
|
Harasawa, Ryô |
|
1995 |
13 |
1 |
p. 100-103 4 p. |
artikel |
3 |
A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections
|
de la Maza, Michael A. |
|
1995 |
13 |
1 |
p. 119-127 9 p. |
artikel |
4 |
An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses
|
Race, Esther |
|
1995 |
13 |
1 |
p. 54-60 7 p. |
artikel |
5 |
Calendar
|
|
|
1995 |
13 |
1 |
p. 136- 1 p. |
artikel |
6 |
Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titres of binding antibodies and toxicity of the formulations
|
Stieneker, Frank |
|
1995 |
13 |
1 |
p. 45-53 9 p. |
artikel |
7 |
Considerations on the use of Neisseria meningitidis class 5 proteins as meningococcal BC vaccine components
|
Sacchi, Claudio Tavares |
|
1995 |
13 |
1 |
p. 112-118 7 p. |
artikel |
8 |
Contribution of electrostatic and hydrophobic interactions to the adsorption of proteins by aluminium-containing adjuvants
|
Al-Shakhshir, Ragheb H. |
|
1995 |
13 |
1 |
p. 41-44 4 p. |
artikel |
9 |
Cross-protection against influenza virus infection in mice vaccinated by combined nasal/subcutaneous administration
|
Asanuma, Hideki |
|
1995 |
13 |
1 |
p. 3-5 3 p. |
artikel |
10 |
Does envelope V3 peptide comprise the principal neutralizing determinant for HIV?
|
Slobod, Karen S. |
|
1995 |
13 |
1 |
p. 129- 1 p. |
artikel |
11 |
Editorial Board
|
|
|
1995 |
13 |
1 |
p. IFC- 1 p. |
artikel |
12 |
Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs
|
Bernstein, David I. |
|
1995 |
13 |
1 |
p. 72-76 5 p. |
artikel |
13 |
Effects of muramyl dipeptide derivatives as adjuvants on the induction of antibody response to recombinant hepatitis B surface antigen
|
Tamura, Mizuho |
|
1995 |
13 |
1 |
p. 77-82 6 p. |
artikel |
14 |
Evaluation of a recombinant Schistosoma mansoni 28 kDa antigen for vaccination of zebu calves against S. bovis
|
Aradaib, Imadeldin E. |
|
1995 |
13 |
1 |
p. 130- 1 p. |
artikel |
15 |
Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children
|
Scheifele, David W. |
|
1995 |
13 |
1 |
p. 104-108 5 p. |
artikel |
16 |
Flavivirus e.g. variola virus recombinant surface antigen protein production and expression using e.g. a vacconia virus vector; application as an attenuated recombinant vaccine
|
|
|
1995 |
13 |
1 |
p. 128- 1 p. |
artikel |
17 |
Human immunodeficiency virus-1 principal neutralizing domain peptide-toxin A conjugate vaccine
|
Cryz Jr, S.J. |
|
1995 |
13 |
1 |
p. 67-71 5 p. |
artikel |
18 |
Immunogenicity in calves of a crude ribosomal fraction of Trichophyton verrucosum: A field trial
|
Elad, D. |
|
1995 |
13 |
1 |
p. 83-87 5 p. |
artikel |
19 |
Modified recombinant virus; antitumour recombinant vaccine production with vaccinia virus or canarypox virus vector and tumour necrosis factor, tumour-associated antigen, interleukin, interferon gene, etc.
|
|
|
1995 |
13 |
1 |
p. 128- 1 p. |
artikel |
20 |
Nucleic acid vaccines
|
Spier, R.E. |
|
1995 |
13 |
1 |
p. 131-132 2 p. |
artikel |
21 |
Protection of goats against peste des petits ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus
|
Romero, C.H. |
|
1995 |
13 |
1 |
p. 36-40 5 p. |
artikel |
22 |
Protection of guinea-pigs from experimental Rocky Mountain spotted fever by immunization with baculovirus-expressed Rickettsia rickettsii rOmpA protein
|
Sumner, John W. |
|
1995 |
13 |
1 |
p. 29-35 7 p. |
artikel |
23 |
Recombinant vaccine composed of luminal antigen domain, cytoplasm endosome-lysosome targeting signal and a recombinant vaccinia virus vector; DNA sequence; potential cancer gene therapy
|
|
|
1995 |
13 |
1 |
p. 128- 1 p. |
artikel |
24 |
Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primates
|
Baqar, Shahida |
|
1995 |
13 |
1 |
p. 22-28 7 p. |
artikel |
25 |
Safety and immunogenicity study of the auxotrophic Shigella flexneri 2a vaccine SFL1070 with a deleted aroD gene in adult Swedish volunteers
|
Kärnell, Anders |
|
1995 |
13 |
1 |
p. 88-99 12 p. |
artikel |
26 |
Simultaneous injection of plasma-derived or recombinant hepatitis B vaccines with yellow fever and killed polio vaccines
|
Coursaget, P. |
|
1995 |
13 |
1 |
p. 109-111 3 p. |
artikel |
27 |
The Hitchner B1 strain of Newcastle disease virus induces high levels of IgA, IgG and IgM in newly hatched chicks
|
Russell, P.H. |
|
1995 |
13 |
1 |
p. 61-66 6 p. |
artikel |
28 |
The sixth international conference on Lyme Borreliosis: Progress on the development of lyme disease vaccines
|
Edelman, Robert |
|
1995 |
13 |
1 |
p. 133-135 3 p. |
artikel |
29 |
Vaccination with a formalin-killed P-fimbriated E. coli whole-cell vaccine prevents renal scarring from pyelonephritis in the non-human primate
|
Roberts, J.A. |
|
1995 |
13 |
1 |
p. 11-16 6 p. |
artikel |
30 |
Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults
|
McElhaney, Janet E. |
|
1995 |
13 |
1 |
p. 6-10 5 p. |
artikel |
31 |
Yersinia enterocolitica and Yersinia pseudotuberculosis invasive structural gene inv expression in Escherichia coli using plasmid pBR322; application as a recombinant vaccine and in pathogen screening
|
|
|
1995 |
13 |
1 |
p. 128- 1 p. |
artikel |